Skip to content
Eli Lilly

Eli Lilly

LLYNYSEHealth Care
1,357.82价格
$10.40 (0.77%)盘后
$1.2T市值

关于 Eli Lilly(LLY)

礼来是一家制药公司,专注于神经科学、心血管代谢、癌症和免疫学领域。礼来的主要产品包括:用于癌症治疗的 Verzenio 和 Jaypirca;用于心血管代谢领域的 Mounjaro、Zepbound、Foundayo、Jardiance、Trulicity、Humalog 和 Humulin;以及用于免疫学领域的 Taltz 和 Olumiant。

CEO
David A. Ricks
员工数
50K
总部
United States
板块
Health Care
行业
PHARMACEUTICAL PREPARATIONS
交易所
NYSE
代币
LLYc
链
Base

数据

市值
$1.2T
营收(TTM)
$86.5B
每股收益(TTM)
$30.81
市盈率
43.72x
负债权益比
1.23x
毛利率
83.88%
净利率
26.44%
流动比率
1.39x
下次财报
Feb 3, 2027
昨日成交量
3.5M
日均成交量
2.9M
今开
$1,362.38
昨收
$1,347.42
今日区间
$1,341.76 – $1,372.05
昨日区间
$1,341.76 – $1,372.05
52 周区间
股息率
0.51%

财报

Eli Lilly 于 2026年10月29日 公布每股收益(EPS)为 $7.48,高于预期的 $5.71,超出 31.00%。 Eli Lilly 预计将于 2027年2月3日 发布下一期财报,EPS 预期为 $11.23。

$12.50
$10.94
$9.38
$7.81
$6.25
$4.69
$3.13
$1.56
$0.00
26年2月+ 9.12%
26年4月+ 22.67%
26年8月+ 30.94%
26年10月+ 31.00%
27年2月--

目标价

分析师对 LLY 股价的预测。

$940.00$1,700.00
当前价$1,357.82目标价8.3%$1,470.06

股票评级

分析师对 LLY 股票的建议,评分从 1(买入)到 5(卖出)。

买入
强力买入 16%
买入 65%
持有 13%
卖出 3%
强力卖出 3%

基于 31 位分析师

Eli Lilly 股票新闻

Australia's first GLP-1 weight-loss tablets are here. How do they compare to injections?

Australia's first GLP-1 weight-loss tablets are here. How do they compare to injections?

sbs.com.au ·

Eli Lilly CEO David Ricks Is Using the Weight-Loss Boom to Buy His Next Bet

Eli Lilly CEO David Ricks Is Using the Weight-Loss Boom to Buy His Next Bet

observer.com ·

Eli Lilly's Next Big Growth Opportunity Could Be Hiding in Plain Sight

Eli Lilly's Next Big Growth Opportunity Could Be Hiding in Plain Sight

fool.com ·

Eli Lilly Is Near Its High. Bank of America Sees Another 19%

Eli Lilly Is Near Its High. Bank of America Sees Another 19%

finance.yahoo.com ·

Eli Lilly Landis Facility Sells for About $100M to BlackRock Unit

Eli Lilly Landis Facility Sells for About $100M to BlackRock Unit

hoodline.com ·

Analysts Are Bullish on Top Healthcare Stocks: Solid Biosciences (SLDB), Eli Lilly & Co (LLY)

Analysts Are Bullish on Top Healthcare Stocks: Solid Biosciences (SLDB), Eli Lilly & Co (LLY)

theglobeandmail.com ·

Eli Lilly Hit With Puerto Rican Worker’s Employment Bias Suit

Eli Lilly Hit With Puerto Rican Worker’s Employment Bias Suit

news.bloomberglaw.com ·

SUMMIT Substudy Reveals Tirzepatide’s Impact on LV, Atrial Metrics of HFpEF

SUMMIT Substudy Reveals Tirzepatide’s Impact on LV, Atrial Metrics of HFpEF

hcplive.com ·

What Does Eli Lilly Offer That Merck Does Not?

What Does Eli Lilly Offer That Merck Does Not?

finance.yahoo.com ·

GLP-1 vision warning: Could demand be affected?

GLP-1 vision warning: Could demand be affected?

foodnavigator.com ·

买入 LLYc